scholarly journals Management challenges for chronic dysimmune neuropathies during the COVID ‐19 pandemic

2020 ◽  
Vol 62 (1) ◽  
pp. 34-40 ◽  
Author(s):  
Yusuf A. Rajabally ◽  
H. Stephan Goedee ◽  
Shahram Attarian ◽  
Hans‐Peter Hartung
Keyword(s):  
Dysimmune Neuropathies

Economic and quality of life evaluation of different modalities of immunoglobulin therapy in chronic dysimmune neuropathies

2012 ◽  
Vol 17 (4) ◽  
pp. 426-428 ◽  
Author(s):  
Dario Cocito ◽  
Grazia Serra ◽  
Ilaria Paolasso ◽  
Diego A. Barilà ◽  
Leonardo Lopiano ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Immunoglobulin Therapy ◽  
Life Evaluation ◽  
Dysimmune Neuropathies

scholarly journals Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges

2020 ◽  
Vol 48 (1) ◽  
pp. 56-64
Author(s):  
A. S. Rizvanova ◽  
D. A. Grishina ◽  
N. A. Suponeva
Keyword(s):  
Clinical Presentation ◽  
Chronic Inflammatory Demyelinating Polyneuropathy ◽  
Demyelinating Polyneuropathy ◽  
Disease Entity ◽  
Laboratory Methods ◽  
Inflammatory Demyelinating Polyneuropathy ◽  
Sensory Disturbances ◽  
Variable Sensitivity ◽  
Dysimmune Neuropathies ◽  
Response Current

Сhronic inflammatory demyelinating polyneuropathy (CIDP) is the most prevalent acquired dysimmune neuropathy with clinical picture of symmetric motor and sensory disturbances. Since the first description of CIDP, many atypical variants have been described, which may reach up to 50% of cases. Diagnosis of atypical CIDP may be challenging due to different clinical presentation and treatment response. Current researches improve our knowledge about dysimmune neuropathies and highlight the importance of its classification. Nowadays CIDP is considered as a spectrum of disorders rather than a separate disease entity. Up to date, more than 15 diagnostic criteria have been proposed reflecting the complexity of СIDP diagnosis. Many polyneuropathies may mimic CIDP, therefore CIDP is frequently a diagnosis of exclusion. The key diagnostic instrument is electroneuromyography; however, the issues related to results misinterpretation and some technical aspects are the most important in CIDP misdiagnosis. Supportive instrumental and laboratory methods have variable sensitivity and specificity, making challenging CIDP diagnosis, especially its atypical forms. The importance of an early and accurate diagnosis of CIDP is supported by an effective pathogenic treatment, which affects the patient's prognosis and level of disability.

Mycophenolate mofetil in dysimmune neuropathies: A preliminary study

2004 ◽  
Vol 29 (5) ◽  
pp. 748-749 ◽  
Author(s):  
Luana Benedetti ◽  
Marina Grandis ◽  
Lucilla Nobbio ◽  
Alessandro Beronio ◽  
Elisabetta Ghiglione ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Preliminary Study ◽  
Dysimmune Neuropathies

Anti-alpha- and beta-tubulin IgM antibodies in dysimmune neuropathies

1995 ◽  
Vol 133 (1-2) ◽  
pp. 79-84 ◽  
Author(s):  
Emanuela Manfredini ◽  
Eduardo Nobile-Orazio ◽  
Silvia Allaria ◽  
Guglielmo Scarlato
Keyword(s):  
Beta Tubulin ◽  
Igm Antibodies ◽  
Dysimmune Neuropathies
Sign in / Sign up

Export Citation Format

Share Document